オープン アクセスを義務付けられた論文 - Shibo Jiang詳細
一般には非公開: 23 件
Development of peptide and small‐molecule HIV‐1 fusion inhibitors that target gp41
L Cai, S Jiang
ChemMedChem 5 (11), 1813-1824, 2010
委任: US National Institutes of Health
Long-term survival of SARS-CoV-2 on salmon as a source for international transmission
M Dai, H Li, N Yan, J Huang, L Zhao, S Xu, J Wu, S Jiang, C Pan, M Liao
The Journal of infectious diseases 223 (3), 537-539, 2021
委任: National Natural Science Foundation of China
Real-time imaging of individual virion-triggered cortical actin dynamics for human immunodeficiency virus entry into resting CD4 T cells
W Yin, W Li, Q Li, Y Liu, J Liu, M Ren, Y Ma, Z Zhang, X Zhang, Y Wu, ...
Nanoscale 12 (1), 115-129, 2020
委任: Chinese Academy of Sciences, National Natural Science Foundation of China
Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents
M Dong, J Zhang, X Peng, H Lu, L Yun, S Jiang, Q Dai
European journal of medicinal chemistry 45 (9), 4096-4103, 2010
委任: US National Institutes of Health
Synergistic effect resulting from combinations of a bifunctional HIV-1 antagonist with antiretroviral drugs
W Xu, Q Wang, F Yu, L Lu, S Jiang
JAIDS Journal of Acquired Immune Deficiency Syndromes 67 (1), 1-6, 2014
委任: US National Institutes of Health, National Natural Science Foundation of China
Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41
W Xu, J Pu, S Su, C Hua, X Su, Q Wang, S Jiang, L Lu
AIDS 33 (10), 1545-1555, 2019
委任: National Natural Science Foundation of China
Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat–C-terminal heptad repeat interactions and C-peptides’ anti-HIV activity
B Zheng, K Wang, L Lu, F Yu, M Cheng, S Jiang, K Liu, L Cai
Aids 28 (9), 1251-1260, 2014
委任: National Natural Science Foundation of China
From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domain
Y Wu, S Jiang, T Ying
Expert opinion on biological therapy 16 (12), 1469-1478, 2016
委任: National Natural Science Foundation of China
Sodium copper chlorophyllin is highly effective against enterovirus (EV) A71 infection by blocking its entry into the host cell
Z Liu, S Xia, X Wang, Q Lan, P Li, W Xu, Q Wang, L Lu, S Jiang
ACS Infectious Diseases 6 (5), 882-890, 2020
委任: National Natural Science Foundation of China
A “two-birds-one-stone” approach toward the design of bifunctional human immunodeficiency virus type 1 entry inhibitors targeting the CCR5 coreceptor and gp41 N-terminal heptad …
C Wang, X Wang, H Wang, J Pu, Q Li, J Li, Y Liu, L Lu, S Jiang
Journal of Medicinal Chemistry 64 (15), 11460-11471, 2021
委任: National Natural Science Foundation of China
A nanoparticle-encapsulated non-nucleoside reverse-transcriptase inhibitor with enhanced anti-HIV-1 activity and prolonged circulation time in plasma
W Li, Q Wang, Y Li, F Yu, Q Liu, B Qin, L Xie, L Lu, S Jiang
Current pharmaceutical design 21 (7), 925-935, 2015
委任: National Natural Science Foundation of China
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 …
D Kong, Y Wang, P Ji, W Li, T Ying, J Huang, C Wang, Y Wu, Y Wang, ...
Aids 32 (13), 1749-1761, 2018
委任: US National Institutes of Health, National Natural Science Foundation of China
Supercoiling structure-based design of a trimeric coiled-coil peptide with high potency against HIV-1 and human β-coronavirus infection
C Wang, S Xia, X Wang, Y Li, H Wang, R Xiang, Q Jiang, Q Lan, R Liang, ...
Journal of Medicinal Chemistry 65 (4), 2809-2819, 2021
委任: National Natural Science Foundation of China
An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells
Q Wang, S Su, J Xue, F Yu, J Pu, W Bi, S Xia, Y Meng, C Wang, W Yang, ...
Science Translational Medicine 12 (546), eaaz2254, 2020
委任: National Natural Science Foundation of China
A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41
X Jiang, Q Jia, L Lu, F Yu, J Zheng, W Shi, L Cai, S Jiang, K Liu
Amino acids 48 (12), 2867-2873, 2016
委任: National Natural Science Foundation of China
A CCR5 antagonist-based HIV entry inhibitor exhibited potent spermicidal activity: Potential application for contraception and prevention of HIV sexual transmission
M Yang, R Zhi, L Lu, M Dong, Y Wang, F Tian, M Xia, J Hu, Q Dai, S Jiang, ...
European Journal of Pharmaceutical Sciences 117, 313-320, 2018
委任: National Natural Science Foundation of China
Viral entry inhibitors targeting six-helical bundle core against highly pathogenic enveloped viruses with class I fusion proteins
J Pu, JT Zhou, P Liu, F Yu, X He, L Lu, S Jiang
Current Medicinal Chemistry 29 (4), 700-718, 2022
委任: National Natural Science Foundation of China
Repurposing Navitoclax to block SARS‐CoV‐2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein
F Jiao, AM Andrianov, L Wang, KV Furs, AV Gonchar, Q Wang, W Xu, L Lu, ...
Journal of Medical Virology 95 (10), e29145, 2023
委任: National Natural Science Foundation of China
Multitargeted drug design strategy for discovery of short-peptide-based HIV-1 entry inhibitors with high potency
C Wang, H Wang, X Wang, L Sun, Q Wang, Q Li, R Liang, D Dou, F Yu, ...
European Journal of Medicinal Chemistry 252, 115294, 2023
委任: National Natural Science Foundation of China
A natural “GA” insertion mutation in the sequence encoding the 3′ UTR of CXCL12/SDF-1α: Identification, characterization, and functional impact on mRNA splicing
X Zhao, D Zhu, H Zhang, H Sui, V Poon, S Jiang, B Zheng
Gene 681, 36-44, 2019
委任: National Natural Science Foundation of China
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます